Navigation Links
Aviir Secures Third $10 Million Financing Tranche To Fund Expanded Sales Of New Heart Risk Test
Date:6/21/2013

Irvine, CA (PRWEB) June 21, 2013

Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, today announced that its current investor group, including its newest investor Partners & Partners, has funded the third $10 million tranche that rounds out the total financing of $30 million initiated in December 2011. This financing was again triggered by the company’s successful achievement of revenue milestones ahead of schedule.

The proceeds will be used to build out commercial infrastructure, accelerate the nationwide commercial launch, broaden third-party reimbursement and initiate foreign distribution of MIRISK VP™, Aviir’s proprietary cardiac risk assessment technology, and additional laboratory testing services. Merck Global Health Innovation Fund led the round, and was joined by Partners & Partners. Current investors Bay City Capital, Aberdare Ventures, and New Leaf Venture Partners also participated.

Douglas Harrington, M.D., CEO of Aviir commented, “Our pilot and regional launch programs have generated both enthusiastic response among the physician community and commercial adoption. The additional funding will now allow us to conduct a more broad commercial launch domestically and take the next steps toward a comprehensive international distribution plan to be rolled out later this year.”

Harrington continued, “The MIRISK test determines an individual’s risk of experiencing future cardiac events, enabling them to take preventive action before it is too late. 50% of people who have a heart attack have normal cholesterol levels, but cholesterol is only part of the risk equation. More than 70% of heart attacks are caused by the rupture of unstable plaque in the arteries, which leads to clotting and heart attacks. The MIRISK test serves as an early warning system that this condition may be present and, importantly, can be addressed.
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood
2. Aviir Laboratories Announce National Agreement With MultiPlan
3. Aviir Laboratories Announce National Agreement with Three Rivers Provider Network
4. Aviir Laboratories Announce National Agreement with Stratose
5. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
6. Aviir, Inc.s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Womens Expo
7. Aviir Sponsors Eco Hideaway 2013 Music Artist Stage At The Chateaux In Park City, Utah To Benefit Heart Disease
8. Aviir Signs Distribution and Expansion Pact Covering 19 Middle Eastern and North African Countries
9. Aviir Signs Distribution And Expansion Pact Covering 19 Middle Eastern And North African Countries
10. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
11. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... DUBLIN , September 19, 2014 ... Research and Markets ( http://www.researchandmarkets.com/research/b2jxhs/micro_market ) has announced the ... Pre-packed Chromatography Columns"  report to their offering.  ... columns market is one of the fastest-growing segments ... at $1.2 billion in 2013, and expected to ...
(Date:9/18/2014)... 2014 HealthTronics, Inc ., ... radiology products and services, announced that a poster ... cryoablation) versus external beam radiotherapy (EBRT) is being ... Urological Association (MAAUA) Annual Meeting in Baltimore, Maryland ... of Cryosurgery and External Beam Radiation as Treatments ...
(Date:9/18/2014)... Mich. , Sept. 18, 2014  Health Enhancement Products, ... firm investigating early-stage algae bioactive compounds and metabolic processes, is ... the company,s board of directors. Ms. Nola E. Masterson ... investment advisor joined the board effective September 17, 2014. ... Masterson agree to join our board," states Andrew Dahl ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... cells are undifferentiated biological cells that can differentiate into ... more stem cells. Stem cell therapy can be applied ... hematological system disease), nervous system diseases, damage or lesion ...
Breaking Biology Technology:Micro Market Monitor : Global Pre-packed Chromatography Columns 2HealthTronics Announces Data Comparing Cryotherapy Versus Radiation for Treating Prostate Cancer Poster Presented at the American Urological Association Regional Meeting 2Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3
... LONDON, May 14 Campbell Alliance,the leading management ... today announced that Gary Tyson, Senior Vice,President of ... on managing the global rollout of electronic data ... The event will be,held on May 28-29, 2008, ...
... Bio Partners B.V., a leading,GMP biopharmaceutical manufacturer, announced ... of ActoGeniX, drug substance AG011 for use in ... ActoGeniX is focused on the development and ... that can,be orally administered. The Company,s lead product ...
... Novavax, Inc. (Nasdaq:,NVAX) Novavax today announced Chief Executive Officer ... Healthcare Conference at,5:05 am Eastern time (11:05 am CEST) ... Monaco, the company announced today., Dr. Singhvi will ... progress and its unique manufacturing solution. A,link to an ...
Cached Biology Technology:Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe 2Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe 3SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 2SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 3
(Date:9/18/2014)... tropical rabbitfish which have devastated algal forests in the ... entire Mediterranean basin if their distribution continues to expand ... study, by an international team of researchers led by ... Tomas of the Mediterranean Institute for Advanced Studies in ... ., Members of the team surveyed more than 1000 ...
(Date:9/18/2014)... September 18, 2014 Elsevier, a world-leading provider ... services, and the Australasian Research Management Society (ARMS), ... scientists at the 5th Scopus Young Researcher of ... earlier today at the National Convention Centre and ... was attended by guests representing Australia,s and New ...
(Date:9/18/2014)... the roaches of the fish world, are the ideal ... body shape. They,ve moved from the ocean into tens ... world, each time changing their skeleton to adapt to ... freshwater populations of sticklebacks now have turned up one ... that a simple change in that gene,s regulation in ...
Breaking Biology News(10 mins):Tropical fish a threat to Mediterranean Sea ecosystems 2Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3
... 12 companies selected for BOSS-U $497 million awardRESTON, ... Biometrics Task Force has selected Raytheon Company (NYSE: ... and support to enhance the ability of the ... biometric defense capabilities. The Biometrics Operations and Support ...
... Scientists and engineers will face a host of ... to millions of people caught up in a water ... today at a briefing at the Broadcast Center of ... the American Chemical Society,s Global Challenges/Chemistry Solutions. ...
... from Obsessive-Compulsive Disorder (OCD). But when do you cross the ... five minutes and mental illness? According to new Tel ... treat OCD is to look at ourselves as though we,re ... us to videotape people that suffer from overt compulsions and ...
Cached Biology News:Raytheon Chosen to Help Provide Department of Defense Biometrics Operations and Support Services 2Substantial work ahead for water issues, say scientists at ACS' Final Report briefing 2Substantial work ahead for water issues, say scientists at ACS' Final Report briefing 3Biofeedback from the zoo 2
... 2 real-time PCR detection system uses a ... (470-505 nm) and two photomultiplier tubes for ... Opticon 2 system is built on an ... thermal gradient feature. This item includes the ...
Fingerprinting II Informatix cluster analysis is an optional module that adds dendrogram and phylogenetic tree construction, cluster and group significance, and congruence of techniques functions to ...
... Fingerprinting II ... is an optional ... principal component analysis, ... analysis and MANOVA, ...
... PrecisION Ion Channel Cell Lines ,High ... ,Ion channels are well known for having ... function and consequently have a key function ... that modulate ion channels have been investigated ...
Biology Products: